ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg), Tabletten - 100
68472006 Devatis AG
Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg), Tabletten01.12.2021
Generic01.12.2021
Levodopa and Decarboxylase Inhibitor (N04BA02) 
WHO-DDD30.11.2026
01.08.100
01.08. 
B  
Yes 
IP 
17.44No
    
10 %35.40
7680684720062Synthetika
  
Composition
benserazidum 50 mg ut benserazidi hydrochloridum, levodopum 200 mg, natrii docusas, E 172 (rubrum), ethylcellulosum, silica colloidalis anhydrica, cellulosum microcristallinum, amylum pregelificatum, mannitolum, calcii hydrogenophosphas, crospovidonum, magnesii stearas, pro compresso corresp. natrium 0.01035 mg.
Packungsbestandteile
Tabletten 
 
Active AgentDose
Benserazidum50 mg
Levodopa200 mg
BAG: Active AgentDose
Benserazidum50 mg
Levodopa200 mg
 
Inactive agents additional_information
(Rubrum)  
Amylum Pregelificatum  
Calcii Hydrogenophosphas  
Cellulosum Microcristallinum  
Crospovidonum  
E 172 color.
Ethylcellulosum  
Magnesii Stearas  
Mannitolum  
Natrii Docusas  
Pro Compresso  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 06.01.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home